Pentoxifylline

CAS 6493-05-6 9 current records 7 historicalSmall Molecule

Who holds supplier records for Pentoxifylline? 9 organisations hold a current record for Pentoxifylline: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), Poland (1), Netherlands (1), Mexico (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Pentoxifylline: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pentoxifylline

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pentoxifylline. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Pentoxifylline sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (7)

Certificates of Suitability on the EDQM register for Pentoxifylline, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SUPRIYA LIFESCIENCE LIMITED MumbaiIN
CEP 2018-294 - Rev 02
Pentoxifylline
Sept 2026—
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard GdanskiPL
CEP 2004-246 - Rev 06
Pentoxifylline, Micronised and non-micronised
May 2026Inspected Jul 2026
Poland
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 1998-139 - Rev 07
Pentoxifylline
Apr 2026—
HIKAL LIMITED BengaluruIN
CEP 2005-131 - Rev 05
Pentoxifylline
Feb 2026Inspected Nov 2025
Switzerland
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2000-127 - Rev 07
Pentoxifylline
Jul 2025—
SINBIOTIK S.A. DE C.V. Tlalnepantla de BazMX
CEP 2019-273 - Rev 01
Pentoxifylline
Feb 2024—
ZENTIVA K.S. Praha 10CZ
R1-CEP 2008-012 - Rev 04
Pentoxifylline
May 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Pentoxifylline are no longer active. These show a past filing, not current supply.

Show all 7 historical records
  • India · Inactive DMF 18249 · filed Mar 2005
  • India · Inactive DMF 17345 · filed Apr 2004
  • PLANTEX LTD
    Inactive DMF 11549 · filed Jun 1995
  • POLI INDUSTRIA CHIMICA SPA
    Inactive DMF 8324 · filed Dec 1989
  • Finland · Inactive DMF 7703 · filed Oct 1988
  • DINAMITE DIPHARMA SPA
    Inactive DMF 7639 · filed Aug 1988
  • LABOCHIM
    Inactive DMF 6485 · filed Jul 1986

Overview

Pentoxifylline is a methylxanthine derivative and a non-selective phosphodiesterase inhibitor that is used to improve blood flow in patients with circulation problems. It helps to reduce blood viscosity and increase red blood cell flexibility, thereby improving oxygenation to tissues.

Chemical identity

IUPAC name
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
Canonical SMILES
CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
InChIKey
BYPFEZZEUUWMEJ-UHFFFAOYSA-N
Synonyms
Trental API, bl 191, bl-191, c04ad03, nsc-637086, nsc-758481, oxypentifylline, pentoxil, pentoxiphyllin, trental

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Blood Viscosity Reducer
Physiologic effect
Hematologic Activity Alteration

Therapeutic areas

HematologyVascular DiseasesRheumatology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pentoxifylline?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Pentoxifylline: HIKAL LTD (India), Sun Pharmaceutical Industries Limited (India), Zakłady Farmaceutyczne Polpharma S.A. (Poland), CSPC INNOVATION PHARM CO LTD, TAPI NL BV (Netherlands), Sinbiotik S.a. De C.v (Mexico), SOLARA ACTIVE PHARMA SCIENCES LTD (India) and SUPRIYA LIFESCIENCE LTD (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Pentoxifylline Drug Master Files are active?

HIKAL LTD (DMF 14182), Sun Pharmaceutical Industries Limited (DMF 14987), Zakłady Farmaceutyczne Polpharma S.A. (DMF 20976), CSPC INNOVATION PHARM CO LTD (DMF 25899) and TAPI NL BV (DMF 12562). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Pentoxifylline records mean?

7 organisations have only inactive Type II DMFs for Pentoxifylline. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Pentoxifylline have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Pentoxifylline on the EDQM register, including SUPRIYA LIFESCIENCE LIMITED Mumbai (IN), ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdanski (PL), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), HIKAL LIMITED Bengaluru (IN), SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai (IN) and SINBIOTIK S.A. DE C.V. Tlalnepantla de Baz (MX) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Pentoxifylline supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pentoxifylline?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.